The Effect of High Intensity Intermittent and Combined (Resistant and Endurance) Trainings on Some Anthropometric Indices and Aerobic Performance in Women with Polycystic Ovary Syndrome: A Randomized Controlled Clinical Trial Study
Abstract
Background: Overweight and obesity are associated with cardiometabolic risk in polycystic ovary syndrome (PCOS). Lifestyle adjustment, such as increasing physical activity, is a first-line strategy to treat PCOS. The current study aims to compare and examine the effect of high intensity intermittent training (HIIT) and combined (COM) training on some anthropometric indices and aerobic performance in PCOS females.
Materials and methods: This randomized controlled clinical trial was conducted on 45 women with PCOS divided into three groups receiving HIIT (n=15), COM interventions (n=15) or control group (n=15) for eight weeks. Some anthropometric indices factors including weight, body mass index (BMI), waist to hip ratio (WHR), body fat percent (FP), and visceral adipose tissue (VAT) as well as VO2max were measured at the baseline at the eighth week. Data were analyzed by one-way ANOVA test. Tukey post hoc tests were used to compare the pair differences.
Results: After eight-week intervention, weight, BMI, WHR, FP, and VAT decreased significantly in both groups of COM and HIIT (P0.05). VO2max increased significantly after COM and HIIT interventions relative to the control group (P=0.001); however, HIIT was statically more effective than COM (P=0.011).
Conclusion: The current study revealed that both HIIT and COM trainings could be beneficial in improving some anthropometric indices in addition to aerobic capacity, although HIIT was more effective on aerobic performance…
How strong is the evidence?
Evidence Hub reads this as a randomized trial, done in people. Its evidence level is 2 of 5 (High · randomized trial). Randomized trials of a reasonable size are the strongest single-study design. Reported size: 45 participants or records.
Read the paper
Related studies
- Increased expression of circulating miRNA-93 in women with polycystic ovary syndrome may represent a novel, non-invasive biomarker for diagnosis
- Identification of key genes associated with polycystic ovary syndrome (PCOS) and ovarian cancer using an integrated bioinformatics analysis
- Identification of key pathways and genes in polycystic ovary syndrome via integrated bioinformatics analysis and prediction of small therapeutic molecules
- Regulation of Androgen Receptor Expression Alters AMPK Phosphorylation in the Endometrium: In Vivo and In Vitro Studies in Women with Polycystic Ovary Syndrome
- Effect of oral administration of low-dose follicle stimulating hormone on hyperandrogenized mice as a model of polycystic ovary syndrome
- Systems pharmacology to investigate the interaction of berberine and other drugs in treating polycystic ovary syndrome
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.